Login

Consolidated balance sheet

In millions of USD, except per-share amounts
Q4 FY2015
As of Dec 31, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q2 FY2014
As of Jun 30, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q3 FY2012
As of Sep 30, 2012
Q2 FY2012
As of Jun 30, 2012
Q1 FY2012
As of Mar 31, 2012
Q3 FY2011
As of Sep 30, 2011
ASSETS
Cash
Accounts Receivable
TOTAL ASSETS
LIABILITES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accounts Payable
Accounts payable - related party
Accrued liabilities
Accrued interest
Accrued interest - related party
Notes payable - related parties
Notes payable
Notes payable - related party
Convertible notes payable
Revolving line of credit - related party
Accounts payable and other accrued liabilities
TOTAL LIABILITIES
STOCKHOLDERS' EQUITY (DEFICIT):
Series A 8% cumulative convertible preferred stock, $.002 par value 10,000,000 shares authorized, 100,000 issued and outstanding
Common stock, $.001 par value, 100,000,000 shares authorized; 97,937,044 shares issued and outstanding
Common stock, $.001 par value, 100,000,000 shares authorized; 3,595,117 shares issued and outstanding
Additional paid-in capital
Accumulated deficit - re-entered development stage on January 1, 2009
Accumulated deficit
Total stockholders' deficit
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT):

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support